{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38434860", "DateRevised": {"Year": "2024", "Month": "03", "Day": "05"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1021/acsomega.3c07380"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "15"}], "Journal": {"ISSN": "2470-1343", "JournalIssue": {"Volume": "9", "Issue": "8", "PubDate": {"Year": "2024", "Month": "Feb", "Day": "27"}}, "Title": "ACS omega", "ISOAbbreviation": "ACS Omega"}, "ArticleTitle": "Enhancing Solubility and Bioefficacy of Stilbenes by Liposomal Encapsulation-The Case of Macasiamenene F.", "Pagination": {"StartPage": "9027", "EndPage": "9039", "MedlinePgn": "9027-9039"}, "Abstract": {"AbstractText": ["Stilbenes in food and medicinal plants have been described as potent antiphlogistic and antioxidant compounds, and therefore, they present an interesting potential for the development of dietary supplements. Among them, macasiamenene F (MF) has recently been shown to be an effective anti-inflammatory and cytoprotective agent that dampens peripheral and CNS inflammation <i>in vitro</i>. Nevertheless, this promising molecule, like other stilbenes and a large percentage of drugs under development, faces poor water solubility, which results in trickier <i>in vivo</i> administration and low bioavailability. With the aim of improving MF solubility and developing a form optimized for <i>in vivo</i> administration, eight types of conventional liposomal nanocarriers and one type of PEGylated liposomes were formulated and characterized. In order to select the appropriate form of MF encapsulation, the safety of MF liposomal formulations was evaluated on THP-1 and THP-1-XBlue-MD2-CD14 monocytes, BV-2 microglia, and primary cortical neurons in culture. Furthermore, the cellular uptake of liposomes and the effect of encapsulation on MF anti-inflammatory effectiveness were evaluated on THP-1-XBlue-MD2-CD14 monocytes and BV-2 microglia. MF (5 mol %) encapsulated in PEGylated liposomes with an average size of 160 nm and polydispersity index of 0.122 was stable, safe, and the most promising form of MF encapsulation keeping its cytoprotective and anti-inflammatory properties."], "CopyrightInformation": "\u00a9 2024 The Authors. Published by American Chemical Society."}, "AuthorList": [{"Identifier": ["0000-0003-2980-6334"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palack\u00e9ho t\u0159. 1946/1, CZ-612 00 Brno, Czech Republic."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic."}, {"Identifier": [], "Affiliation": "IPMC, UMR 7275, Universit\u00e9 C\u00f4te d'Azur, CNRS, 660 Route des Lucioles, Sophia Antipolis, F-06560 Valbonne, France."}], "LastName": "Brezani", "ForeName": "Veronika", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "IPMC, UMR 7275, Universit\u00e9 C\u00f4te d'Azur, CNRS, 660 Route des Lucioles, Sophia Antipolis, F-06560 Valbonne, France."}], "LastName": "Blondeau", "ForeName": "Nicolas", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic."}], "LastName": "Kotou\u010dek", "ForeName": "Jan", "Initials": "J"}, {"Identifier": ["0000-0002-6984-1268"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 753/5, CZ-625 00 Brno, Czech Republic."}], "LastName": "Kl\u00e1skov\u00e1", "ForeName": "Eva", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, Palack\u00e9ho t\u0159. 1946/1, CZ-612 00 Brno, Czech Republic."}], "LastName": "\u0160mejkal", "ForeName": "Karel", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Pharmacy, Faculty of Pharmacy, Masaryk University, Palack\u00e9ho t\u0159. 1946/1, CZ-612 00 Brno, Czech Republic."}, {"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic."}], "LastName": "Ho\u0161ek", "ForeName": "Jan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic."}], "LastName": "Ma\u0161kov\u00e1", "ForeName": "Eli\u0161ka", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic."}], "LastName": "Kulich", "ForeName": "Pavel", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chulabhorn Research Institute, Kamphaeng Phet 6 Road, Laksi, TH-10210 Bangkok, Thailand."}], "LastName": "Prachyawarakorn", "ForeName": "Vilailak", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "IPMC, UMR 7275, Universit\u00e9 C\u00f4te d'Azur, CNRS, 660 Route des Lucioles, Sophia Antipolis, F-06560 Valbonne, France."}], "LastName": "Heurteaux", "ForeName": "Catherine", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Veterinary Research Institute, Hudcova 296/70, CZ-621 00 Brno, Czech Republic."}], "LastName": "Ma\u0161ek", "ForeName": "Josef", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "ACS Omega", "NlmUniqueID": "101691658", "ISSNLinking": "2470-1343"}, "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Alsk\u00e4r L. C.; Porter C. J. H.; Bergstr\u00f6m C. A. S. Tools for Early Prediction of Drug Loading in Lipid-Based Formulations. Mol. Pharmaceutics 2016, 13 (1), 251\u2013261. 10.1021/acs.molpharmaceut.5b00704.", "ArticleIdList": ["10.1021/acs.molpharmaceut.5b00704", "PMC4928820", "26568134"]}, {"Citation": "Savjani K. T.; Gajjar A. K.; Savjani J. K. Drug Solubility: Importance and Enhancement Techniques. ISRN Pharm. 2012, 2012, 19572710.5402/2012/195727.", "ArticleIdList": ["10.5402/2012/195727", "PMC3399483", "22830056"]}, {"Citation": "Bonechi C.; Martini S.; Ciani L.; Lamponi S.; Rebmann H.; Rossi C.; Ristori S. Using Liposomes as Carriers for Polyphenolic Compounds: The Case of Trans-Resveratrol. PLoS One 2012, 7 (8), e4143810.1371/journal.pone.0041438.", "ArticleIdList": ["10.1371/journal.pone.0041438", "PMC3425584", "22936976"]}, {"Citation": "Lee M.-K. Liposomes for Enhanced Bioavailability of Water-Insoluble Drugs: In Vivo Evidence and Recent Approaches. Pharmaceutics 2020, 12 (3), 264.10.3390/pharmaceutics12030264.", "ArticleIdList": ["10.3390/pharmaceutics12030264", "PMC7151102", "32183185"]}, {"Citation": "Balouch M.; Storchmannov\u00e1 K.; \u0160t\u011bp\u00e1nek F.; Berka K. Computational Prodrug Design Methodology for Liposome Formulability Enhancement of Small-Molecule APIs. Mol. Pharmaceutics 2023, 20, 2119.10.1021/acs.molpharmaceut.2c01078.", "ArticleIdList": ["10.1021/acs.molpharmaceut.2c01078", "PMC10074381", "36939094"]}, {"Citation": "Zylberberg C.; Matosevic S. Pharmaceutical Liposomal Drug Delivery: A Review of New Delivery Systems and a Look at the Regulatory Landscape. Drug Delivery 2016, 23 (9), 3319\u20133329. 10.1080/10717544.2016.1177136.", "ArticleIdList": ["10.1080/10717544.2016.1177136", "27145899"]}, {"Citation": "Khan A. R.; Yang X.; Fu M.; Zhai G. Recent Progress of Drug Nanoformulations Targeting to Brain. J. Controlled Release 2018, 291, 37\u201364. 10.1016/j.jconrel.2018.10.004.", "ArticleIdList": ["10.1016/j.jconrel.2018.10.004", "30308256"]}, {"Citation": "Bruch G. E.; Fernandes L. F.; Bassi B. L. T.; Alves M. T. R.; Pereira I. O.; Fr\u00e9zard F.; Massensini A. R. Liposomes for Drug Delivery in Stroke. Brain Res. Bull. 2019, 152, 246\u2013256. 10.1016/j.brainresbull.2019.07.015.", "ArticleIdList": ["10.1016/j.brainresbull.2019.07.015", "31323280"]}, {"Citation": "Monteiro N.; Martins A.; Reis R. L.; Neves N. M. Liposomes in Tissue Engineering and Regenerative Medicine. J. R. Soc. Interface 2014, 11 (101), 2014045910.1098/rsif.2014.0459.", "ArticleIdList": ["10.1098/rsif.2014.0459", "PMC4223894", "25401172"]}, {"Citation": "Inglut C. T.; Sorrin A. J.; Kuruppu T.; Vig S.; Cicalo J.; Ahmad H.; Huang H.-C. Immunological and Toxicological Considerations for the Design of Liposomes. Nanomaterials 2020, 10 (2), 190.10.3390/nano10020190.", "ArticleIdList": ["10.3390/nano10020190", "PMC7074910", "31978968"]}, {"Citation": "Daraee H.; Etemadi A.; Kouhi M.; Alimirzalu S.; Akbarzadeh A. Application of Liposomes in Medicine and Drug Delivery. Artif. Cells Nanomed. Biotechnol. 2016, 44 (1), 381\u2013391. 10.3109/21691401.2014.953633.", "ArticleIdList": ["10.3109/21691401.2014.953633", "25222036"]}, {"Citation": "Sercombe L.; Veerati T.; Moheimani F.; Wu S. Y.; Sood A. K.; Hua S. Advances and Challenges of Liposome Assisted Drug Delivery. Front. Pharmacol. 2015, 6, 28610.3389/fphar.2015.00286.", "ArticleIdList": ["10.3389/fphar.2015.00286", "PMC4664963", "26648870"]}, {"Citation": "Bulbake U.; Doppalapudi S.; Kommineni N.; Khan W. Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 2017, 9 (2), 12.10.3390/pharmaceutics9020012.", "ArticleIdList": ["10.3390/pharmaceutics9020012", "PMC5489929", "28346375"]}, {"Citation": "Hornedo-Ortega R.; Jourdes M.; Da Costa G.; Courtois A.; Gabaston J.; Teissedre P.-L.; Richard T.; Krisa S. Oxyresveratrol and Gnetol Glucuronide Metabolites: Chemical Production, Structural Identification, Metabolism by Human and Rat Liver Fractions, and In Vitro Anti-Inflammatory Properties. J. Agric. Food Chem. 2022, 70 (41), 13082\u201313092. 10.1021/acs.jafc.1c07831.", "ArticleIdList": ["10.1021/acs.jafc.1c07831", "PMC9585577", "35195403"]}, {"Citation": "Lel\u00e1kov\u00e1 V.; \u0160mejkal K.; Jakubczyk K.; Vesel\u00fd O.; Landa P.; V\u00e1clav\u00edk J.; Bob\u00e1\u013e P.; P\u00ed\u017eov\u00e1 H.; Temml V.; Steinacher T.; Schuster D.; Granica S.; Han\u00e1kov\u00e1 Z.; Ho\u0161ek J. Parallel in Vitro and in Silico Investigations into Anti-Inflammatory Effects of Non-Prenylated Stilbenoids. Food Chem. 2019, 285, 431\u2013440. 10.1016/j.foodchem.2019.01.128.", "ArticleIdList": ["10.1016/j.foodchem.2019.01.128", "30797367"]}, {"Citation": "Dvorakova M.; Landa P. Anti-Inflammatory Activity of Natural Stilbenoids: A Review. Pharmacol. Res. 2017, 124, 126\u2013145. 10.1016/j.phrs.2017.08.002.", "ArticleIdList": ["10.1016/j.phrs.2017.08.002", "28803136"]}, {"Citation": "Bradamante S.; Barenghi L.; Villa A. Cardiovascular Protective Effects of Resveratrol. Cardiovasc. Drug Rev. 2004, 22 (3), 169\u2013188. 10.1111/j.1527-3466.2004.tb00139.x.", "ArticleIdList": ["10.1111/j.1527-3466.2004.tb00139.x", "15492766"]}, {"Citation": "Chen P.-C.; Tsai W.-J.; Ueng Y.-F.; Tzeng T.-T.; Chen H.-L.; Zhu P.-R.; Huang C.-H.; Shiao Y.-J.; Li W.-T. Neuroprotective and Antineuroinflammatory Effects of Hydroxyl-Functionalized Stilbenes and 2-Arylbenzo[b]Furans. J. Med. Chem. 2017, 60 (9), 4062\u20134073. 10.1021/acs.jmedchem.7b00376.", "ArticleIdList": ["10.1021/acs.jmedchem.7b00376", "28459572"]}, {"Citation": "Biais B.; Krisa S.; Cluzet S.; Da Costa G.; Waffo-Teguo P.; M\u00e9rillon J.-M.; Richard T. Antioxidant and Cytoprotective Activities of Grapevine Stilbenes. J. Agric. Food Chem. 2017, 65 (24), 4952\u20134960. 10.1021/acs.jafc.7b01254.", "ArticleIdList": ["10.1021/acs.jafc.7b01254", "28551990"]}, {"Citation": "Vesely O.; Baldovska S.; Kolesarova A. Enhancing Bioavailability of Nutraceutically Used Resveratrol and Other Stilbenoids. Nutrients 2021, 13 (9), 3095.10.3390/nu13093095.", "ArticleIdList": ["10.3390/nu13093095", "PMC8470508", "34578972"]}, {"Citation": "Amri A.; Chaumeil J. C.; Sfar S.; Charrueau C. Administration of Resveratrol: What Formulation Solutions to Bioavailability Limitations?. J. Controlled Release 2012, 158 (2), 182\u2013193. 10.1016/j.jconrel.2011.09.083.", "ArticleIdList": ["10.1016/j.jconrel.2011.09.083", "21978644"]}, {"Citation": "Censi R.; Di Martino P. Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs. Molecules 2015, 20 (10), 18759\u201318776. 10.3390/molecules201018759.", "ArticleIdList": ["10.3390/molecules201018759", "PMC6331817", "26501244"]}, {"Citation": "Ho\u0161ek J.; Lel\u00e1kov\u00e1 V.; Bob\u00e1l P.; P\u00ed\u017eov\u00e1 H.; Gazdov\u00e1 M.; Malan\u00edk M.; Jakubczyk K.; Vesel\u00fd O.; Landa P.; Temml V.; Schuster D.; Prachyawarakorn V.; Pailee P.; Ren G.; Zpurn\u00fd F.; Oravec M.; \u0160mejkal K. Prenylated Stilbenoids Affect Inflammation by Inhibiting the NF-\u03baB/AP-1 Signaling Pathway and Cyclooxygenases and Lipoxygenase. J. Nat. Prod 2019, 82 (7), 1839\u20131848. 10.1021/acs.jnatprod.9b00081.", "ArticleIdList": ["10.1021/acs.jnatprod.9b00081", "31268709"]}, {"Citation": "Lel\u00e1kov\u00e1 V.; B\u00e9raud-Dufour S.; Ho\u0161ek J.; \u0160mejkal K.; Prachyawarakorn V.; Pailee P.; Widmann C.; V\u00e1clav\u00edk J.; Coppola T.; Mazella J.; Blondeau N.; Heurteaux C. Therapeutic Potential of Prenylated Stilbenoid Macasiamenene F through Its Anti-Inflammatory and Cytoprotective Effects on LPS-Challenged Monocytes and Microglia. J. Ethnopharmacol. 2020, 263, 11314710.1016/j.jep.2020.113147.", "ArticleIdList": ["10.1016/j.jep.2020.113147", "32736058"]}, {"Citation": "Fukuta T.; Ishii T.; Asai T.; Oku N. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke. Biol. Pharm. Bull. 2019, 42 (3), 319\u2013326. 10.1248/bpb.b18-00683.", "ArticleIdList": ["10.1248/bpb.b18-00683", "30828062"]}, {"Citation": "Montesinos R. N.Liposomal Drug Delivery to the Central Nervous System; IntechOpen, 2017."}, {"Citation": "Vieira D. B.; Gamarra L. F. Getting into the Brain: Liposome-Based Strategies for Effective Drug Delivery across the Blood\u2013Brain Barrier. Int. J. Nanomed. 2016, 11, 5381\u20135414. 10.2147/IJN.S117210.", "ArticleIdList": ["10.2147/IJN.S117210", "PMC5077137", "27799765"]}, {"Citation": "Fukuta T.; Asai T.; Sato A.; Namba M.; Yanagida Y.; Kikuchi T.; Koide H.; Shimizu K.; Oku N. Neuroprotection against Cerebral Ischemia/Reperfusion Injury by Intravenous Administration of Liposomal Fasudil. Int. J. Pharm. 2016, 506 (1\u20132), 129\u2013137. 10.1016/j.ijpharm.2016.04.046.", "ArticleIdList": ["10.1016/j.ijpharm.2016.04.046", "27107903"]}, {"Citation": "Fukuta T.; Ishii T.; Asai T.; Sato A.; Kikuchi T.; Shimizu K.; Minamino T.; Oku N. Treatment of Stroke with Liposomal Neuroprotective Agents under Cerebral Ischemia Conditions. Eur. J. Pharm. Biopharm. 2015, 97 (Pt A), 1\u20137. 10.1016/j.ejpb.2015.09.020.", "ArticleIdList": ["10.1016/j.ejpb.2015.09.020", "26455340"]}, {"Citation": "Yoneda S.; Fukuta T.; Ozono M.; Kogure K. Enhancement of Cerebroprotective Effects of Lipid Nanoparticles Encapsulating FK506 on Cerebral Ischemia/Reperfusion Injury by Particle Size Regulation. Biochem. Biophys. Res. Commun. 2022, 611, 53\u201359. 10.1016/j.bbrc.2022.04.080.", "ArticleIdList": ["10.1016/j.bbrc.2022.04.080", "35477093"]}, {"Citation": "Agrawal M.; Ajazuddin; Tripathi D. K.; Swarnlata S.; Shailendra S.; Antimisiaris S. G.; Mourtas S.; Hammarlund-Udenaes M.; Alexander A. Recent Advancements in Liposomes Targeting Strategies to Cross Blood-Brain Barrier (BBB) for the Treatment of Alzheimer\u2019s Disease. J. Controlled Release 2017, 260, 61\u201377. 10.1016/j.jconrel.2017.05.019.", "ArticleIdList": ["10.1016/j.jconrel.2017.05.019", "28549949"]}, {"Citation": "Arias-Alpizar G.; Kong L.; Vlieg R. C.; Rabe A.; Papadopoulou P.; Meijer M. S.; Bonnet S.; Vogel S.; van Noort J.; Kros A.; Campbell F. Light-Triggered Switching of Liposome Surface Charge Directs Delivery of Membrane Impermeable Payloads in Vivo. Nat. Commun. 2020, 11 (1), 363810.1038/s41467-020-17360-9.", "ArticleIdList": ["10.1038/s41467-020-17360-9", "PMC7371701", "32686667"]}, {"Citation": "Suk J. S.; Xu Q.; Kim N.; Hanes J.; Ensign L. M. PEGylation as a Strategy for Improving Nanoparticle-Based Drug and Gene Delivery. Adv. Drug Delivery Rev. 2016, 99 (Pt A), 28\u201351. 10.1016/j.addr.2015.09.012.", "ArticleIdList": ["10.1016/j.addr.2015.09.012", "PMC4798869", "26456916"]}, {"Citation": "Koudelka \u0160.; Tur\u00e1nek-Kn\u00f6tigov\u00e1 P.; Ma\u0161ek J.; Korvasov\u00e1 Z.; \u0160krabalov\u00e1 M.; Plockov\u00e1 J.; Bartheldyov\u00e1 E.; Tur\u00e1nek J. Liposomes with High Encapsulation Capacity for Paclitaxel: Preparation, Characterisation and in Vivo Anticancer Effect. J. Pharm. Sci. 2010, 99 (5), 2309\u20132319. 10.1002/jps.21992.", "ArticleIdList": ["10.1002/jps.21992", "19904827"]}, {"Citation": "\u0160ime\u010dkov\u00e1 P.; Hubatka F.; Kotou\u010dek J.; Tur\u00e1nek Kn\u00f6tigov\u00e1 P.; Ma\u0161ek J.; Slav\u00edk J.; Kov\u00e1\u010d O.; Ne\u010da J.; Kulich P.; Hreb\u00edk D.; Str\u00e1sk\u00e1 J.; P\u011bn\u010d\u00edkov\u00e1 K.; Proch\u00e1zkov\u00e1 J.; Divi\u0161 P.; Macaulay S.; Mikul\u00edk R.; Ra\u0161ka M.; Machala M.; Tur\u00e1nek J. Gadolinium Labelled Nanoliposomes as the Platform for MRI Theranostics: In Vitro Safety Study in Liver Cells and Macrophages. Sci. Rep. 2020, 10 (1), 478010.1038/s41598-020-60284-z.", "ArticleIdList": ["10.1038/s41598-020-60284-z", "PMC7075985", "32179785"]}, {"Citation": "Coimbra M.; Isacchi B.; van Bloois L.; Torano J. S.; Ket A.; Wu X.; Broere F.; Metselaar J. M.; Rijcken C. J. F.; Storm G.; Bilia R.; Schiffelers R. M. Improving Solubility and Chemical Stability of Natural Compounds for Medicinal Use by Incorporation into Liposomes. Int. J. Pharm. 2011, 416 (2), 433\u2013442. 10.1016/j.ijpharm.2011.01.056.", "ArticleIdList": ["10.1016/j.ijpharm.2011.01.056", "21291975"]}, {"Citation": "Beaumont P.; Faure C.; Courtois A.; Jourdes M.; Marchal A.; Teissedre P.-L.; Richard T.; Atgi\u00e9 C.; Krisa S. Trans-\u03b5-Viniferin Encapsulation in Multi-Lamellar Liposomes: Consequences on Pharmacokinetic Parameters, Biodistribution and Glucuronide Formation in Rats. Nutrients 2021, 13 (12), 4212.10.3390/nu13124212.", "ArticleIdList": ["10.3390/nu13124212", "PMC8708455", "34959765"]}, {"Citation": "Danaei M.; Dehghankhold M.; Ataei S.; Hasanzadeh Davarani F.; Javanmard R.; Dokhani A.; Khorasani S.; Mozafari M. R. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics 2018, 10 (2), 5710.3390/pharmaceutics10020057.", "ArticleIdList": ["10.3390/pharmaceutics10020057", "PMC6027495", "29783687"]}, {"Citation": "Filippov S. K.; Khusnutdinov R.; Murmiliuk A.; Inam W.; Zakharova L. Y.; Zhang H.; Khutoryanskiy V. V. Dynamic Light Scattering and Transmission Electron Microscopy in Drug Delivery: A Roadmap for Correct Characterization of Nanoparticles and Interpretation of Results. Mater. Horiz. 2023, 10 (12), 5354\u20135370. 10.1039/D3MH00717K.", "ArticleIdList": ["10.1039/D3MH00717K", "37814922"]}, {"Citation": "Bellow S.; Latouche G.; Brown S. C.; Poutaraud A.; Cerovic Z. G. In Vivo Localization at the Cellular Level of Stilbene Fluorescence Induced by Plasmopara Viticola in Grapevine Leaves. J. Exp. Bot. 2012, 63 (10), 3697\u20133707. 10.1093/jxb/ers060.", "ArticleIdList": ["10.1093/jxb/ers060", "PMC3388817", "22412183"]}, {"Citation": "Cadena P. G.; Pereira M. A.; Cordeiro R. B. S.; Cavalcanti I. M. F.; Barros Neto B.; Pimentel M. do C. C. B.; Lima Filho J. L.; Silva V. L.; Santos-Magalh\u00e3es N. S. Nanoencapsulation of Quercetin and Resveratrol into Elastic Liposomes. Biochim. Biophys. Acta 2013, 1828 (2), 309\u2013316. 10.1016/j.bbamem.2012.10.022.", "ArticleIdList": ["10.1016/j.bbamem.2012.10.022", "23103506"]}, {"Citation": "Pecyna P.; Wargula J.; Murias M.; Kucinska M. More Than Resveratrol: New Insights into Stilbene-Based Compounds. Biomolecules 2020, 10 (8), 1111.10.3390/biom10081111.", "ArticleIdList": ["10.3390/biom10081111", "PMC7465418", "32726968"]}, {"Citation": "Zhou T.; Jiang Y.; Zeng B.; Yang B. The Cancer Preventive Activity and Mechanisms of Prenylated Resveratrol and Derivatives. Curr. Res. Toxicol. 2023, 5, 10011310.1016/j.crtox.2023.100113.", "ArticleIdList": ["10.1016/j.crtox.2023.100113", "PMC10382290", "37519844"]}, {"Citation": "Yang S.-C.; Tseng C.-H.; Wang P.-W.; Lu P.-L.; Weng Y.-H.; Yen F.-L.; Fang J.-Y. Pterostilbene, a Methoxylated Resveratrol Derivative, Efficiently Eradicates Planktonic, Biofilm, and Intracellular MRSA by Topical Application. Front. Microbiol. 2017, 8, 1103.10.3389/fmicb.2017.01103.", "ArticleIdList": ["10.3389/fmicb.2017.01103", "PMC5468402", "28659908"]}, {"Citation": "Lel\u00e1kov\u00e1 V.Evaluation of the Influence of Selected Stilbenes on Neuroprotection against Stroke with a Focus on Inflammatory Signaling, Doctoral Dissertation; Universit\u00e9 C\u00f4te d\u2019Azur: Nice, France; Masaryk University: Brno, Czech Republic, 2020."}, {"Citation": "Chang C.-C.; Liu D.-Z.; Lin S.-Y.; Liang H.-J.; Hou W.-C.; Huang W.-J.; Chang C.-H.; Ho F.-M.; Liang Y.-C. Liposome Encapsulation Reduces Cantharidin Toxicity. Food Chem. Toxicol. 2008, 46 (9), 3116\u20133121. 10.1016/j.fct.2008.06.084.", "ArticleIdList": ["10.1016/j.fct.2008.06.084", "18652872"]}, {"Citation": "Pailee P.; Sangpetsiripan S.; Mahidol C.; Ruchirawat S.; Prachyawarakorn V. Cytotoxic and Cancer Chemopreventive Properties of Prenylated Stilbenoids from Macaranga Siamensis. Tetrahedron 2015, 71 (34), 5562\u20135571. 10.1016/j.tet.2015.06.058.", "ArticleIdList": ["10.1016/j.tet.2015.06.058"]}, {"Citation": "Kuronuma K.; Mitsuzawa H.; Takeda K.; Nishitani C.; Chan E. D.; Kuroki Y.; Nakamura M.; Voelker D. R. Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-Interacting Proteins CD14 and MD-2. J. Biol. Chem. 2009, 284 (38), 25488\u201325500. 10.1074/jbc.M109.040832.", "ArticleIdList": ["10.1074/jbc.M109.040832", "PMC2757950", "19584052"]}, {"Citation": "Numata M.; Voelker D. R. \u2032Inflammatory and Anti-Viral Actions of Anionic Pulmonary Surfactant Phospholipids. Biochim. Biophys. Acta 2022, 1867 (6), 15913910.1016/j.bbalip.2022.159139.", "ArticleIdList": ["10.1016/j.bbalip.2022.159139", "PMC9050941", "35240310"]}, {"Citation": "Filion M. C.; Phillips N. C. Anti-Inflammatory Activity of Cationic Lipids. Br. J. Pharmacol. 1997, 122 (3), 551\u2013557. 10.1038/sj.bjp.0701396.", "ArticleIdList": ["10.1038/sj.bjp.0701396", "PMC1564955", "9351514"]}, {"Citation": "Kann O.; Kov\u00e1cs R. Mitochondria and Neuronal Activity. Am. J. Physiol. Cell Physiol. 2007, 292 (2), C641\u2013C657. 10.1152/ajpcell.00222.2006.", "ArticleIdList": ["10.1152/ajpcell.00222.2006", "17092996"]}, {"Citation": "Azzazy H. M. E.; Hong K.; Wu M.-C.; Gross G. W. Interaction of Cationic Liposomes with Cells of Electrically Active Neuronal Networks in Culture. Brain Res. 1995, 695 (2), 231\u2013236. 10.1016/0006-8993(95)00710-8.", "ArticleIdList": ["10.1016/0006-8993(95)00710-8", "8556335"]}, {"Citation": "Cui S.; Wang Y.; Gong Y.; Lin X.; Zhao Y.; Zhi D.; Zhou Q.; Zhang S. Correlation of the Cytotoxic Effects of Cationic Lipids with Their Headgroups. Toxicol. Res. 2018, 7 (3), 473\u2013479. 10.1039/C8TX00005K.", "ArticleIdList": ["10.1039/C8TX00005K", "PMC6062336", "30090597"]}, {"Citation": "Filion M. C.; Phillips N. C. Toxicity and Immunomodulatory Activity of Liposomal Vectors Formulated with Cationic Lipids toward Immune Effector Cells. Biochim. Biophys. Acta 1997, 1329 (2), 345\u2013356. 10.1016/S0005-2736(97)00126-0.", "ArticleIdList": ["10.1016/S0005-2736(97)00126-0", "9371426"]}, {"Citation": "Takano S.; Aramaki Y.; Tsuchiya S. Physicochemical Properties of Liposomes Affecting Apoptosis Induced by Cationic Liposomes in Macrophages. Pharm. Res. 2003, 20 (7), 962\u2013968. 10.1023/A:1024441702398.", "ArticleIdList": ["10.1023/A:1024441702398", "12880280"]}, {"Citation": "Arias J. L. Liposomes in Drug Delivery: A Patent Review (2007 \u2013 Present). Expert Opin. Ther. Pat. 2013, 23 (11), 1399\u20131414. 10.1517/13543776.2013.828035.", "ArticleIdList": ["10.1517/13543776.2013.828035", "23957267"]}, {"Citation": "Huang M.; Liang C.; Tan C.; Huang S.; Ying R.; Wang Y.; Wang Z.; Zhang Y. Liposome Co-Encapsulation as a Strategy for the Delivery of Curcumin and Resveratrol. Food Funct. 2019, 10 (10), 6447\u20136458. 10.1039/C9FO01338E.", "ArticleIdList": ["10.1039/C9FO01338E", "31524893"]}, {"Citation": "Narayanan N. K.; Nargi D.; Randolph C.; Narayanan B. A. Liposome Encapsulation of Curcumin and Resveratrol in Combination Reduces Prostate Cancer Incidence in PTEN Knockout Mice. Int. J. Cancer 2009, 125 (1), 1\u20138. 10.1002/ijc.24336.", "ArticleIdList": ["10.1002/ijc.24336", "19326431"]}, {"Citation": "Soo E.; Thakur S.; Qu Z.; Jambhrunkar S.; Parekh H. S.; Popat A. Enhancing Delivery and Cytotoxicity of Resveratrol through a Dual Nanoencapsulation Approach. J. Colloid Interface Sci. 2016, 462, 368\u2013374. 10.1016/j.jcis.2015.10.022.", "ArticleIdList": ["10.1016/j.jcis.2015.10.022", "26479200"]}, {"Citation": "Wei X.-Q.; Zhu J.-F.; Wang X.-B.; Ba K. Improving the Stability of Liposomal Curcumin by Adjusting the Inner Aqueous Chamber pH of Liposomes. ACS Omega 2020, 5 (2), 1120\u20131126. 10.1021/acsomega.9b03293.", "ArticleIdList": ["10.1021/acsomega.9b03293", "PMC6977029", "31984268"]}, {"Citation": "Peng R.-M.; Lin G.-R.; Ting Y.; Hu J.-Y. Oral Delivery System Enhanced the Bioavailability of Stilbenes: Resveratrol and Pterostilbene. Biofactors 2018, 44 (1), 5\u201315. 10.1002/biof.1405.", "ArticleIdList": ["10.1002/biof.1405", "29322567"]}, {"Citation": "Nasri H.; Baradaran A.; Shirzad H.; Rafieian-Kopaei M. New Concepts in Nutraceuticals as Alternative for Pharmaceuticals. Int. J. Prev. Med. 2014, 5 (12), 1487\u20131499.", "ArticleIdList": ["PMC4336979", "25709784"]}, {"Citation": "Tauskela J. S.; Aylsworth A.; Hewitt M.; Brunette E.; Blondeau N. Failure and Rescue of Preconditioning-Induced Neuroprotection in Severe Stroke-like Insults. Neuropharmacology 2016, 105, 533\u2013542. 10.1016/j.neuropharm.2016.02.007.", "ArticleIdList": ["10.1016/j.neuropharm.2016.02.007", "26867506"]}, {"Citation": "Vohl\u00eddalov\u00e1 E.Inkorporace Macasiamenene F Do Liposom\u016f \u2013 Fyzik\u00e1ln\u00ed Charakterizace [Incorporation of Macasiamenene F into Liposomes \u2013 Physical Characterization, Advanced Master\u2019s Thesis; Veterin\u00e1rn\u00ed a Farmaceutick\u00e1 Univerzita Brno: Brno, 2020."}, {"Citation": "Blasi E.; Barluzzi R.; Bocchini V.; Mazzolla R.; Bistoni F. Immortalization of Murine Microglial Cells by a V-Raf/v-Myc Carrying Retrovirus. J. Neuroimmunol. 1990, 27 (2\u20133), 229\u2013237. 10.1016/0165-5728(90)90073-V.", "ArticleIdList": ["10.1016/0165-5728(90)90073-V", "2110186"]}, {"Citation": "Bourourou M.; Gouix E.; Melis N.; Friard J.; Heurteaux C.; Tauc M.; Blondeau N. Inhibition of eIF5A Hypusination Pathway as a New Pharmacological Target for Stroke Therapy. J. Cereb. Blood Flow Metab. 2021, 41 (5), 1080\u20131090. 10.1177/0271678X20928882.", "ArticleIdList": ["10.1177/0271678X20928882", "PMC8054730", "32615885"]}, {"Citation": "Triantafilou K.; Triantafilou M.; Dedrick R. L. A CD14-Independent LPS Receptor Cluster. Nat. Immunol. 2001, 2 (4), 338.10.1038/86342.", "ArticleIdList": ["10.1038/86342", "11276205"]}, {"Citation": "Taka E.; Mazzio E. A.; Goodman C. B.; Redmon N.; Flores-Rozas H.; Reams R.; Darling-Reed S.; Soliman K. F. A. Anti-Inflammatory Effects of Thymoquinone in Activated BV-2 Microglia Cells. J. Neuroimmunol. 2015, 286, 5\u201312. 10.1016/j.jneuroim.2015.06.011.", "ArticleIdList": ["10.1016/j.jneuroim.2015.06.011", "PMC4548297", "26298318"]}]}], "History": [{"Year": "2023", "Month": "9", "Day": "24"}, {"Year": "2024", "Month": "1", "Day": "22"}, {"Year": "2024", "Month": "1", "Day": "26"}, {"Year": "2024", "Month": "3", "Day": "4", "Hour": "6", "Minute": "45"}, {"Year": "2024", "Month": "3", "Day": "4", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "3", "Day": "4", "Hour": "4", "Minute": "52"}, {"Year": "2024", "Month": "2", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["38434860", "PMC10905713", "10.1021/acsomega.3c07380"]}}]}